US FDA narrows COVID-19 vaccine eligibility for under-65s, keeps full access for seniors
Pfizer
WASHINGTON: The US Food and Drug Administration (FDA) on Wednesday (Aug 27) approved updated COVID-19 vaccines for everyone aged 65 and over but narrowed access for younger people to those with health risks, a shift from previous years when most Americans were eligible. The three approved shots are made by Pfizer and German partner BioNTech, Moderna, and Novavax with Sanofi. “Today’s decision does not affect access to these vaccines. These vaccines remain available to those who choose them in
din zilele anterioare